Skip to content

ANGX ANGX Operating lease right-of-use asset amortization

Operating lease right-of-use asset amortization at other companies

Dolby Laboratories, Inc. logo
Dolby Laboratories, Inc.DLB

Other financials

Income statement

See full
Revenue$115.1M+143%
Gross profit$71.1M+154%
Operating income-$2.7M+92.1%
Net income-$13.8M+63.0%
EPS (diluted)-$0.08+68.0%

Balance sheet

See full
Cash & equivalents$38.9M+10,871%
Total debt$64.8M
Total equity-$10.2M-184%
Total assets$213.1M+20,635%

Cash flow

See full
Operating cash flow$1.9M+119%

Valuation

See full
Market cap$546.03M-74.4%
Enterprise value$571.99M
P/S1.4×

Profitability

See full
Gross margin61.6%
Operating margin-28.8%
Net margin-34.1%

Returns & leverage

See full
Current ratio0.6×+0.5×

Where this comes from

Reported directly by ANGX in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.

The official record: ANGX’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANGX's operating lease right-of-use asset amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ANGX's operating lease right-of-use asset amortization?
ANGX (ANGX) reported operating lease right-of-use asset amortization of $307.47K in Q1 2026.
How has ANGX's operating lease right-of-use asset amortization changed year-over-year?
ANGX's operating lease right-of-use asset amortization increased by 79.3% year-over-year, from $171.52K to $307.47K.